中国社区医师Issue(3)：24-24,26,2.DOI:10.3969/j.issn.1007-614x.2015.3.14
蛇毒血凝酶治疗肺结核大咯血的临床效果及不良反应观察
Observation of the clinical effect and adverse reaction of hemocoagulase in the treatment of pulmonary tuberculosis hemoptysis
摘要
Abstract
Objective:To observe and evaluate the clinical effect and security of hemocoagulase in the treatment of pulmonary tuberculosis hemoptysis.Methods:24 patients with pulmonary tuberculosis hemoptysis were selected.The clinical data were retrospectively analyzed.12 cases of hypophysin + nitroglycerin bleeding were selected as the control group.12 cases of hemocoagulase intramuscular were selected as the observation group.The related indicators were compared.Results:The onset time of the observation group (5±1)minutes,the haemoptysis disappeared time (2±2)hours,the amount of hemoptysis (310±207) mL were lower than (14±9)minutes,(28±15)hours and (582±174)mL of the control group.The recurrence rate 0.00% and the adverse reaction incidence rate 0.00% of the observation group during hospitalization were lower than 41.67% and 50.00% of the control group.The differences were statistically significant(P<0.05).Conclusion:The hemocoagulase in the treatment of pulmonary tuberculosis hemoptysis has quickly hemostatic speed and high first time success rate,low recurrence rate and less adverse reaction.The operation is simple.It is ideal pulmonary tuberculosis hemoptysis hemostatic agent,but its use needs to have a certain predictability.关键词
肺结核/大咯血/蛇毒血凝酶/临床效果/不良反应Key words
Pulmonary tuberculosis/Hemoptysis/Hemocoagulase/Clinical effect/Adverse reaction引用本文复制引用
刘俊婷..蛇毒血凝酶治疗肺结核大咯血的临床效果及不良反应观察[J].中国社区医师,2015,(3):24-24,26,2.
